Gertz MA. Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management. Am J Hematol. 2017;92:209.

Article  PubMed  CAS  Google Scholar 

Cambier J-F, Ronco P. Onco-Nephrology. Clin J Am Soc Nephrol. 2012;7:1701.

Article  PubMed  CAS  Google Scholar 

Haraguchi S, Tomiyoshi Y, Aoki S, Sakemi T. Nephrotic syndrome due to immunologically mediated hypocomplementic glomerulonephritis in a patient of Waldenstrom’s macroglobulinemia. Nephron. 2002;92:452–5.

Article  PubMed  Google Scholar 

Kofman T, Zhang S-Y, Copie-Bergman C, Moktefi A, Raimbourg Q, Francois H, et al. Minimal change nephrotic syndrome associated with non-hodgkin lymphoid disorders. Medicine. 2014;93:350.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Miyoshi H, Ohshima K. Epidemiology of malignant lymphoma and recent progress in research on adult T-cell leukemia/lymphoma in Japan. Int J Hematol. 2018;107:420.

Article  PubMed  CAS  Google Scholar 

Chihara D, Ito H, Matsuda T, Shibata A, Katsumi A, Nakamura S, et al. Differences in incidence and trends of haematological malignancies in Japan and the United States. Brit J Haematol. 2013;164:536.

Article  Google Scholar 

Ronco PM. Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int. 1999;56:355–77.

Article  PubMed  CAS  Google Scholar 

Audard V, Larousserie F, Grimbert P, Abtahi M, Sotto J-J, Delmer A, et al. Minimal change nephrotic syndrome and classical Hodgkin’s lymphoma: report of 21 cases and review of the literature. Kidney Int. 2006;69:2251–60.

Article  PubMed  CAS  Google Scholar 

Aggarwal N, Batwara R, McCarthy ET, Sharma R, Sharma M, Savin VJ. Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease. Am J Kidney Dis. 2007;50:826–9.

Article  PubMed  CAS  Google Scholar 

Lien Y-HH, Lai L-W. Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis. Nat Rev Nephrol. 2011;7:85.

Article  PubMed  CAS  Google Scholar 

Purohit S, Piani F, Ordoñez FA, De Lucas-Collantes C, Bauer C, Cara-Fuentes G. Molecular mechanisms of proteinuria in minimal change disease. Front Med. 2021;8:761600.

Article  Google Scholar 

Higgins L, Nasr SH, Said SM, Kapoor P, Dingli D, King RL, et al. Kidney involvement of patients with waldenström macroglobulinemia and other IgM-Producing B Cell lymphoproliferative disorders. Clin J Am Soc Nephrol. 2018;13:1037.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Vos JM, Gustine J, Rennke HG, Hunter Z, Manning RJ, Dubeau TE, et al. Renal disease related to Waldenström macroglobulinaemia: incidence, pathology and clinical outcomes. Br J Haematol. 2016;175:623–30.

Article  PubMed  CAS  Google Scholar 

Uppal NN, Monga D, Vernace MA, Mehtabdin K, Shah HH, Bijol V, et al. Kidney diseases associated with Waldenström macroglobulinemia. Nephrol Dial Transplant. 2019;34:1644–52.

Article  PubMed  CAS  Google Scholar 

Martins M, Bridoux F, Goujon JM, Meuleman MS, Ribes D, Rondeau E, et al. Complement activation and thrombotic microangiopathy associated with monoclonal gammopathy: a national french case series. Am J Kidney Dis. 2022;80:341–52.

Article  PubMed  CAS  Google Scholar 

Filippone EJ, Newman ED, Li L, Gulati R, Farber JL. Thrombotic microangiopathy, an unusual form of monoclonal gammopathy of renal significance: report of 3 cases and literature review. Front Immunol. 2021;12:780107.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Colucci M, Oniszczuk J, Vivarelli M, Audard V. B-Cell dysregulation in idiopathic nephrotic syndrome: what we know and what we need to discover. Front Immunol. 2022;13:823204.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Salviani C, Guido G, Serriello I, Giannakakis K, Rocca AR. Renal involvement in Waldenström’s macroglobulinemia: case report and review of literature. Renal Fail. 2013;36:114.

Article  Google Scholar 

Meyrier A, Niaudet P. Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int. 2018;94:861–9.

Article  PubMed  Google Scholar 

Owen RG, Kyle RA, Stone MJ, Rawstron AC, Leblond V, Merlini G, et al. Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop. Br J Haematol. 2013;160:171–6.

Article  PubMed  Google Scholar 

Chauvet S, Bridoux F, Ecotière L, Javaugue V, Sirac C, Arnulf B, et al. Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients. Am J Kidney Dis. 2015;66:756–67.

Article  PubMed  CAS  Google Scholar 

Takei T, Nitta K. Rituximab and minimal change nephrotic syndrome: a therapeutic option. Clin Exp Nephrol. 2011;15:641–7.

Article  PubMed  CAS  Google Scholar 

Gilbert RD, Hulse E, Rigden S. Rituximab therapy for steroid-dependent minimal change nephrotic syndrome. Pediat Nephrol (Berlin, Germany). 2006;21:1698–700.

Article  Google Scholar